• Bacterial Culture, Cerebrospinal Fluid (CSF)
  • 17-Hydroxyprogesterone, Urine
  • Parasites Smear (Giemsa Stain), Blood
  • Dihydrocodeine, Urine
  • Francisella Tularensis Antibody, IgG
  • Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • Gene Expression Profile for Cutaneous Melanoma, DermTech (DecisionDx®-SCC), Pigmented Lesion Assay (PLA), myPath® Melanoma
  • Bromazepam
  • Antinuclear Antibody (ANA), IFA Patterning
  • Peripheral Myelin Protein 22 (PMP22), Peripheral Neuropathy, FISH
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
Medical Test

References
Access to OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment is restricted.